Does METAMIZOLE Cause Basal cell carcinoma? 12 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Basal cell carcinoma have been filed in association with METAMIZOLE. This represents 0.2% of all adverse event reports for METAMIZOLE.
12
Reports of Basal cell carcinoma with METAMIZOLE
0.2%
of all METAMIZOLE reports
1
Deaths
12
Hospitalizations
How Dangerous Is Basal cell carcinoma From METAMIZOLE?
Of the 12 reports, 1 (8.3%) resulted in death, 12 (100.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METAMIZOLE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does METAMIZOLE Cause?
Nausea (451)
Agranulocytosis (438)
Vomiting (410)
Off label use (370)
Drug ineffective (352)
Pyrexia (322)
Dyspnoea (316)
General physical health deterioration (307)
Pain (281)
Abdominal pain (278)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which METAMIZOLE Alternatives Have Lower Basal cell carcinoma Risk?
METAMIZOLE vs METARAMINOL
METAMIZOLE vs METAXALONE
METAMIZOLE vs METFORMIN
METAMIZOLE vs METFORMIN\PIOGLITAZONE
METAMIZOLE vs METFORMIN\ROSIGLITAZONE